Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
91 hedge funds and large institutions have $369M invested in Myovant Sciences Ltd. in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 13 closing their positions.
15% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 13
2% more funds holding
Funds holding: 89 → 91 (+2)
0% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 29
5% less call options, than puts
Call options by funds: $8.33M | Put options by funds: $8.73M
8% less capital invested
Capital invested by funds: $400M → $369M (-$30.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$7M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$6.99M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$3.51M |
| 4 |
JP Morgan Chase
New York
|
+$2.41M |
| 5 |
Goldman Sachs
New York
|
+$2.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$12.2M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$4.47M |
| 3 |
PC
Pier Capital
Stamford,
Connecticut
|
-$3.93M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.57M |
| 5 |
Morgan Stanley
New York
|
-$2.48M |
MYOV Hedge Fund Activity: Q2 2022 in Review
91 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q2 2022, worth a combined $369M — down 7.7% from $400M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new MYOV positions and 13 closed out — a net gain of 2 holders — while 29 added to existing stakes and 29 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $7M. The largest seller was State Street, cutting an estimated $12.2M.
- 91 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q2 2022, up from 89 in Q1 2022.
- Funds reported $369M of Myovant Sciences Ltd. stock for Q2 2022, down 7.7% quarter-over-quarter.
- 15 funds opened new Myovant Sciences Ltd. positions in Q2 2022 and 13 closed out, a net change of +2 holders.
- The largest Myovant Sciences Ltd. buyer in Q2 2022 was Wellington Management Group, an estimated $7M added.
- The largest Myovant Sciences Ltd. seller in Q2 2022 was State Street, an estimated $12.2M sold.
Based on aggregated 13F filings for Q2 2022.